Platelet-activating factor antagonists do not attenuate delayed posttraumatic cerebral edema in rats

Area of Science:

• Neuroscience
• Pharmacology
• Pathophysiology

Background:

• Platelet-activating factor (PAF) receptor antagonists have shown promise in improving neurological recovery and cerebral blood flow in experimental models of ischemia.
• However, their impact on posttraumatic cerebral edema has not been previously investigated.

Purpose of the Study:

• To evaluate the efficacy of two PAF receptor antagonists, BN 52021 and WEB 2086, in mitigating posttraumatic cerebral edema.
• To determine the role of PAF in the development of cerebral edema following traumatic brain injury.

Main Methods:

• A rat model of right hemispheric percussive cerebral trauma was utilized.
• Animals received intravenous administration of either BN 52021 or WEB 2086 (10 mg/kg) or their respective vehicles 15 minutes post-trauma.
• Percent brain water content was measured in the affected hemisphere 24 hours after injury.

Main Results:

• Cerebral edema formation was observed in all experimental groups.
• Neither BN 52021 nor WEB 2086 treatment resulted in a statistically significant reduction in hemispheric percent brain water compared to vehicle controls.
• No significant differences in mortality rates were observed between the treatment and control groups.

Conclusions:

• The administration of PAF receptor antagonists BN 52021 and WEB 2086 did not effectively reduce posttraumatic cerebral edema in this rat model.
• These results do not support a substantial role for platelet-activating factor (PAF) in the pathogenesis of cerebral edema following traumatic brain injury.